Related Experiment Video
Updated: Mar 27, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Left Ventricular Pacing through Coronary Sinus Is Feasible and Safe for Patients with Prior Tricuspid Valve
Skevos Sideris1, Maria Drakopoulou2, George Oikonomopoulos3
1Cardiology Department, Hippokration Hospital, Athens, Greece.
Insights
Left ventricular pacing via the coronary sinus is a safe and effective option for patients needing pacemakers after tricuspid valve intervention. This minimally invasive approach shows stable long-term outcomes without lead complications.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Tricuspid valve intervention can lead to tricuspid regurgitation, complicating right ventricular lead implantation.
- Left ventricular pacing via the coronary sinus (CS) is an alternative in select cases post-tricuspid valve repair or replacement.
Purpose of the Study:
- To evaluate the long-term clinical outcomes of left ventricular pacing using CS lead implantation in patients with prior tricuspid valve intervention.
Main Methods:
- Retrospective study of 17 consecutive patients requiring pacemaker implantation after tricuspid valve intervention.
- All patients received ventricular rate-responsive (VVIR) devices with CS lead implantation for atrial fibrillation and symptomatic pauses.
Main Results:
- Successful and uncomplicated device implantations with acceptable operation and fluoroscopy times.
- Stable lead performance (sensing, threshold, impedance) at 2-year follow-up with no lead dislodgement.
- Mean R-wave sensing: 7.5 mV, mean pacing threshold: 1.9 V/0.4 ms, mean impedance: 743.5 Ohm.
Conclusions:
- Left ventricular pacing via CS lead is a viable and minimally invasive option for permanent pacing in patients with tricuspid valve intervention.
- This approach offers durable lead performance and avoids risks associated with right ventricular leads in this population.
Background:
In the presence of tricuspid valve intervention, right ventricular lead implantation is associated with the potential risk of tricuspid valve malfunction leading to a tricuspid regurgitation. Few cases have been reported with successful left ventricular pacing via the coronary sinus (CS) after tricuspid valve replacement or repair. In this retrospective study, we present the long-term clinical outcomes of 17 patients who underwent CS lead implantation and left ventricular pacing.
Methods:
Seventeen consecutive patients referred to our institution with an indication of postprocedural pacemaker (PM) implantation after tricuspid valve intervention were retrospectively included in the study. The indication for device implantation in all patients was atrial fibrillation with a symptomatic pause ≥ 3.0 seconds. Thus, all devices implanted were ventricular rate responsive (VVIR).
Results:
All device implantations were successful and uncomplicated. Mean operation time was 60 ± 8 minutes. Mean fluoroscopy time was 8.3 ± 2.1 minutes. Mean R-wave sensing was 7.5 ± 2.0 mV with a mean slew rate of 2.2 V/s. A mean pacing threshold of 1.9 ± 0.3 V/0.4 ms was accepted as patients were not PM-dependent. The pacing impedance was 743.5 ± 109.71 Ohm. At 2-year follow-up, pacing sensing, threshold, and impedance values were unchanged and no lead dislodgement has been noted.
Conclusions:
In patients with tricuspid valve intervention, left ventricular pacing might be the treatment of choice for permanent ventricular pacing, with all the advantages of the endovenous route as a minimally invasive approach.
More Related Videos
10:05Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiac Catheterization III: Left Heart Catheterization
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Cardiac Catheterization II: Right Heart Catheterization